Manufacturer record
Aristo Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
21 batches manufactured by Aristo Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MPL254485, Liquid Paraffin, Magnesium Hydroxide, Sodium Picosulfate Suspension (exp Oct 2027). RDTL, Hubli, Karnataka (state lab) found it not of standard quality: Description only. Listed in the September 2026 alert.
Records by type
21 records linked to Aristo Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Liquid Paraffin, Magnesium Hydroxide, Sodium Picosulfate Suspension | Batch MPL254485Mfg Nov 2025 · Exp Oct 2027 | Description onlyDescription | RDTL, Hubli, KarnatakaState lab | Sep 2026 |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | Batch SPK251470Mfg Oct 2025 · Exp Mar 2028 | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Telmisartan Tablets IP 40 Mg | Batch SPE250642Mfg May 2025 · Exp Apr 2027 | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan 40mg & Amlodipine 5mg Tablets IP | Batch BPH252331Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Pantoprazole Gastro Resistant Tablets IP 40mg | Batch SPG240936Mfg Jul 2024 · Exp Dec 2026 | The sample does not conform to I.P. w.r.to the tests for Identification AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan & Amlodipine Tablets IP | Batch BPF251519Mfg Jun 2025 · Exp May 2027 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
| Pantoprazole & Domperidone Capsules IP | Batch SPJ241197Mfg Sep 2024 · Exp Aug 2026 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
| Cefpodoxime Tablets IP 200 Mg | Batch BPA250167Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
| Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | Batch SPA250021Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Assay of Pantoprazole Sodium calculated as Pantoprazole, Domperidone.Assay | RDTL,ChandigarhCDSCO lab | Nov 2025 |
| Telvas-AM (Telmisartan & Amlodipine Tablets I.P.) | Batch BPG241 827Mfg Jul 2024 · Exp Jun 2026 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Telvas H 40/12.5 (Telmisartan & Hydrochlorothiazide Tablets I.P.) | Batch SPB240 306Mfg Feb 2024 · Exp Jan 2026 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Telvas 40 (Telmisartan Tablets I.P. 40mg.) | Batch SPB240 221Mfg Feb 2024 · Exp Jan 2026 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Cefpodoxime Tablets IP 200 mg (Monocef-O 200) | Batch BPH232520Mfg Aug 2023 · Exp Jul 2025 | Identification and Assay/ Content of CefpodoximeAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Cefpodoxime Tablets IP 200 mg (Monocef-O 200) | Batch BPD231045Mfg Apr 2023 · Exp Mar 2025 | Identification and Assay/ Content of CefpodoximeAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Ceftraixone Injection IP (Monocef 500 mg) | Batch MPD231319Mfg Apr 2023 · Exp Sep 2025 | Clarity of solutionOther | CDL KolkataCDSCO lab | Nov 2023 |
| Monocef - O (Cefpodoxime Tablets IP 200 mg) | Batch BPH222546Mfg Aug 2022 · Exp Jul 2024 | Identification, Assay & Uniformity of weightAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Pantop-DSR� (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged- release Capsules IP) | Batch SPA220030Mfg Jan 2022 · Exp Dec 2023 | Identification and Assay/ Content of ?Pantoprazole and Domperidone?Assay | RDTL GuwahatiState lab | Nov 2022 |
| Pantop- D SR� (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged-release Capsules IP) | Batch SPJ211372Mfg Sep 2021 · Exp Aug 2023 | Identification and Assay/Content of Pantoprazole & Domperidone and DescriptionAssay | RDTL GuwahatiState lab | Nov 2022 |
| Pantop-DSR (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged release Capsules IP) | Batch SPM211927Mfg Dec 2021 · Exp Nov 2023 | Identification and AssayAssay | RDTL GuwahatiState lab | Oct 2022 |
| Delisprin 75 (Aspirin Delayed Release Tablets U.S.P. 75 mg) | Batch M107M018Mfg Dec 2018 · Exp May 2020 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2019 |
| Amlodipine Tablets IP 10 mg (AMLOSAFE 10 TABLETS) | Batch M129L018Mfg Nov 2018 · Exp Oct 2020 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.